- Home
- BCAB vs SOS Comparison
BCAB vs SOS Comparison
Compare BCAB & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- SOS
- Stock Information
- Founded
- BCAB 2007
- SOS 2004
- Country
- BCAB United States
- SOS China
- Employees
- BCAB N/A
- SOS N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- SOS Finance: Consumer Services
- Sector
- BCAB Health Care
- SOS Finance
- Exchange
- BCAB Nasdaq
- SOS Nasdaq
- Market Cap
- BCAB 22.3M
- SOS 19.3M
- IPO Year
- BCAB 2020
- SOS 2017
- Fundamental
- Price
- BCAB $0.41
- SOS $5.76
- Analyst Decision
- BCAB Buy
- SOS
- Analyst Count
- BCAB 2
- SOS 0
- Target Price
- BCAB $1.00
- SOS N/A
- AVG Volume (30 Days)
- BCAB 561.7K
- SOS 15.3K
- Earning Date
- BCAB 08-07-2025
- SOS 05-15-2025
- Dividend Yield
- BCAB N/A
- SOS N/A
- EPS Growth
- BCAB N/A
- SOS N/A
- EPS
- BCAB N/A
- SOS N/A
- Revenue
- BCAB $11,000,000.00
- SOS $231,424,000.00
- Revenue This Year
- BCAB N/A
- SOS N/A
- Revenue Next Year
- BCAB N/A
- SOS N/A
- P/E Ratio
- BCAB N/A
- SOS N/A
- Revenue Growth
- BCAB N/A
- SOS 150.42
- 52 Week Low
- BCAB $0.24
- SOS $4.04
- 52 Week High
- BCAB $2.53
- SOS $15.51
- Technical
- Relative Strength Index (RSI)
- BCAB 44.32
- SOS 45.52
- Support Level
- BCAB $0.38
- SOS $5.75
- Resistance Level
- BCAB $0.46
- SOS $6.04
- Average True Range (ATR)
- BCAB 0.06
- SOS 0.28
- MACD
- BCAB -0.01
- SOS -0.11
- Stochastic Oscillator
- BCAB 9.36
- SOS 1.05
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.